CALA vs. SCPS, STAB, ATHX, APVO, AMPE, OBSV, ALLR, SXTC, ADTX, and PTEIQ
Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Scopus BioPharma (SCPS), Statera Biopharma (STAB), Athersys (ATHX), Aptevo Therapeutics (APVO), Ampio Pharmaceuticals (AMPE), ObsEva (OBSV), Allarity Therapeutics (ALLR), China SXT Pharmaceuticals (SXTC), Aditxt (ADTX), and PolarityTE (PTEIQ). These companies are all part of the "medical" sector.
Scopus BioPharma (NASDAQ:SCPS) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation.
In the previous week, Calithera Biosciences had 1 more articles in the media than Scopus BioPharma. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Scopus BioPharma. Calithera Biosciences' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score.
Scopus BioPharma has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -0.17, meaning that its stock price is 117% less volatile than the S&P 500.
Calithera Biosciences received 339 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 59.82% of users gave Calithera Biosciences an outperform vote.
Scopus BioPharma has higher earnings, but lower revenue than Calithera Biosciences.
Summary
Scopus BioPharma and Calithera Biosciences tied by winning 3 of the 6 factors compared between the two stocks.
Get Calithera Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CALA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Calithera Biosciences Competitors List
Related Companies and Tools
